Peers of Pasithea Therapeutics Corp (KTTA)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
-1258.26x
As of Jun 29, 2023
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Jun 29, 2023 | -1258.26x |
| Jun 28, 2023 | -1351.41x |
| Jun 27, 2023 | -1296.68x |
| Jun 26, 2023 | -1287.07x |
| Jun 23, 2023 | -1287.07x |
| Jun 22, 2023 | -1350.45x |
| Jun 21, 2023 | -1241.17x |
| Jun 20, 2023 | -1243.48x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison